This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




Advertisement Advertisement Advertisement Advertisement
Text Version  RSS  Subscribe  Unsubscribe  Archive  Media Kit December 12, 2014
Home    About AST    Education    Meetings & Events    Public Policy    Contact Us  

 

SOCIETY NEWS

COP contribution contest
AST
To improve our external fundraising efforts, we must first improve our internal philanthropy. Achieving a high participation rate is of paramount importance. Consider a donation today.

The board will award a prize to the COP with the highest percentage of contributing members from now through the end of the year: $2,000 towards a COP initiative in 2015 (must be approved by the AST Board of Directors).
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




AST Government Relations: An obligation to our patients
AST
A critical mission of AST is advocacy. Government decisions increasingly affect all aspects of the transplantation field – and our ability to improve the lives of those with organ failure. Recognizing this reality, AST has significantly strengthened its voice and presence on Capitol Hill, within key federal agencies, and in targeted state capitols over the past decade. Read the full blog post here.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


UPCOMING EVENTS IN TRANSPLANTATION


Mark your calendar: 2015 webinars
AST
AST has you covered for convenient education topics in January and February. Register for these webinars today and have access to the live broadcast and the archive:

Treatment of Antibody-mediated Rejection in Thoracic Transplants
  • Tuesday, Jan. 20, 2015 at 2 p.m. EST
Multiorgan Transplantation: One Organ Too Many?
  • Tuesday, Feb. 10, 2015 at 3 p.m. EST
Medically Complex Living Donors: Candidacy, Care, and Informed Consent
  • Tuesday, Feb. 17, 2015 at 2 p.m. EST
AST also has 30+ webinars available on demand, so you can watch relevant educational videos on your own schedule.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


PRODUCT SHOWCASE
 
You care about your transplant patients. And so do we. That’s why we’re introducing Astellas Cares—a new program that offers you customized tools, educational resources, and comprehensive support to help your patients care for their health. To register, visit AstellasCares.com/Transplant today.
 


Buy one, get one half off plus discounted early registration for a limited time only
The Cutting Edge of Transplantation
Immunity and Inflammation: Engineering Cell, Gene, and Drug Therapies

Feb. 5-7, 2015
Sheraton Wild Horse Pass – Chandler, Arizona

CEOT 2015 is fast approaching, and for a limited time you can save on registration and housing with special discounted promotions. Attend CEOT with a colleague and take advantage of Buy One, Get One Half Off registration, from Dec. 1 thru Jan. 25. Going solo? Early registration discounted rates are in effect from now until Jan. 23. Also, book your hotel stay at the Sheraton Wild Horse Pass by Jan. 12 to guarantee the discounted rate of $211 per night. Join nearly 300 of your colleagues at this high-energy, interactive meeting to explore how we, as a community involved in transplantation, will move the field forward. This year’s CEOT will explore some of the following critical challenges:
  • How can you participate in the future of new drug development?
  • How do we pioneer the repositioning of existing and new drugs?
  • How can the AST champion the necessary change that affords your patients better outcomes?
Register for CEOT at a discount here.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article




TRANSPLANT NEWS


Azithromycin and the treatment of lymphocytic airway inflammation after lung transplantation
American Journal of Transplantation
Lymphocytic airway inflammation is a major risk factor for chronic lung allograft dysfunction, for which there is no established treatment. We investigated whether azithromycin could control lymphocytic airway inflammation and improve allograft function. Fifteen lung transplant recipients demonstrating acute allograft dysfunction due to isolated lymphocytic airway inflammation were prospectively treated with azithromycin for at least 6 months (NCT01109160).
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


COMMITMENT TO CARE
Raptor's mission is to develop and commercialize life-altering therapeutics that treat rare, debilitating, and often fatal diseases.
LEARN MORE
Advertise here!

To find out how to feature your company in the AST eNewsletter and other advertising opportunities, Contact Tom Crist at 972-402-7724.
MORE


Summary of the British Transplantation Society Guidelines for Management of the Failing Kidney Transplant
Transplantation
The British Transplantation Society “Guideline for Transplantation Management of the Failing Kidney Transplant” was published in May 2014. This is the first national guideline in this field. In line with previous guidelines published by the British Transplantation Society, the guideline has used the GRADE system to rate the strength of evidence and recommendations.This article summarizes the Statements of Recommendation contained in the guideline, which provide a framework for the management of the failing kidney graft in the United Kingdom and may be of wide international interest.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  UCLA Immunogenetics Center

The UCLA Immunogenetics Center (UIC) provides comprehensive testing for organ and tissue transplantation. Transplant testing has a long history at UCLA. HLA typing was pioneered here in the 1960's. The development of the microcytoxicity test in 1964 marked the beginning of international testing and standardization of HLA typing. The UCLA Immunogenetics Center has retained its leadership position in HLA research, and in the development of accompanying diagnostic testing. MORE
 


Capacity building in pediatric transplant infectious diseases: An international perspective
Pediatric Transplantation
Transplant infectious diseases is a rapidly emerging subspecialty within pediatric infectious diseases reflecting the increasing volumes and complexity of this patient population. Incorporating transplant infectious diseases into the transplant process would provide an opportunity to improve clinical outcome and advocacy as well as expand research. The relationship between transplant physicians and infectious diseases (ID) specialists is one of partnership, collaboration, and mutual continuing professional education.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




Interleukin-2 receptor antagonists for pediatric liver transplant recipients: A systematic review and meta-analysis of controlled studies
Pediatric Transplantation
IL-2RA are frequently used as induction therapy in liver transplant recipients to decrease the risk of AR while allowing the reduction of concomitant immunosuppression. The exact association with the use of IL-2RA, however, is uncertain. They performed a systematic literature search for relevant studies. Random effects models were used to assess the incidence of AR, steroid-resistant rejection, graft loss, patient death, and adverse drug reaction, with or without IL-2RA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




National assessment of early biliary complications after liver transplantation: Economic implications
Transplantation
Despite improvement in surgical technique and medical management of liver transplant recipients, biliary complications remain a frequent cause of post-transplant morbidity and graft loss. Biliary complications require potentially expensive interventions including radiologic procedures and surgical revisions.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    The new OPTN kidney allocation policy: Potential for inequitable access among highly sensitized patients (American Journal of Transplantation)
Observations on the use of cidofovir for BK virus infection in renal transplantation (Transplant Infectious Disease)
Outcomes of combined liver–kidney transplantation in children: Analysis of the scientific registry of transplant recipients (American Journal of Transplantation)
Fatal Scopulariopsis infection in a lung transplant recipient: Lessons of organ procurement (American Journal of Transplantation)
A 3-gene assay for monitoring immune quiescence in kidney transplantation (Journal of the American Society of Nephrology)

Don't be left behind. Click here to see what else you missed.
 



AST eNews

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Julie Bernhard, Executive Editor, 469.420.2647  
Contribute news


This edition of the AST eNews was sent to ##Email##. To unsubscribe, click here.

Recent issues
Dec. 5, 2014
Nov. 28, 2014
Nov. 21, 2014
Nov. 14, 2014






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063